These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2210078)

  • 21. Factors associated with early remission of type I diabetes in children treated with cyclosporine.
    Bougneres PF; Carel JC; Castano L; Boitard C; Gardin JP; Landais P; Hors J; Mihatsch MJ; Paillard M; Chaussain JL
    N Engl J Med; 1988 Mar; 318(11):663-70. PubMed ID: 3125434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects.
    Martin S; Schernthaner G; Nerup J; Gries FA; Koivisto VA; Dupré J; Standl E; Hamet P; McArthur R; Tan MH
    Diabetologia; 1991 Jun; 34(6):429-34. PubMed ID: 1884902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiological study of the non-insulin-dependent phase of type I diabetes mellitus.
    Torella R; Salvatore T; Cozzolino D; Grandillo F; Giugliano D
    Acta Diabetol Lat; 1988; 25(2):161-72. PubMed ID: 3146849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year.
    Moncada E; Subirá ML; Oleaga A; Goñi F; Sánchez-Ibarrola A; Monreal M; Sevilla M; Goñi MJ; Yoldi A; Terán D
    J Autoimmun; 1990 Oct; 3(5):625-38. PubMed ID: 2252531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
    Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
    Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of clinical remission in recent-onset IDDM.
    Hramiak IM; Dupre J; Finegood DT
    Diabetes Care; 1993 Jan; 16(1):125-32. PubMed ID: 8422766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of disease.
    Stiller CR; Dupre J; Gent M; Heinrichs D; Jenner MR; Keown PA; Laupacis A; Martell R; Rodger NW; Wolfe BM
    J Pediatr; 1987 Dec; 111(6 Pt 2):1069-72. PubMed ID: 3316581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of cyclosporin A on B-cell loss in type 1 (insulin-dependent) diabetes mellitus.
    Vague P; Vialettes B; Picq R; Dol S; Lassmann-Vague V
    Diabetologia; 1989 Dec; 32(12):887. PubMed ID: 2693167
    [No Abstract]   [Full Text] [Related]  

  • 30. Induction and pathophysiology of remission of insulin-dependent diabetes mellitus during administration of ciclosporin. London Diabetes Study Group.
    Dupre J; Hramiak I; Mahon JL; Stiller CR
    Horm Res; 1990; 33(2-4):152-8. PubMed ID: 2210620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.
    Mirouze J; Selam JL; Pham TC; Mendoza E; Orsetti A
    Diabetologia; 1978 Apr; 14(4):223-7. PubMed ID: 640299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary multicentre study of the treatment of recently diagnosed type 1 diabetes by combination nicotinamide-cyclosporin therapy.
    Vialettes B; Picq R; du Rostu M; Charbonnel B; Rodier M; Mirouze J; Vexiau P; Passa P; Pehuet M; Elgrably F
    Diabet Med; 1990; 7(8):731-5. PubMed ID: 2147636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for type 1 (insulin-dependent) diabetes mellitus.
    Bardet S; Rohmer V; Maugendre D; Marre M; Semana G; Limal JM; Allannic H; Charbonnel B; Saï P
    Diabetologia; 1991 Sep; 34(9):648-54. PubMed ID: 1955097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal and infant beta cell hormone concentrations in relation to type 1 diabetes risk.
    Stumpp C; Beyerlein A; Ziegler AG; Bonifacio E
    Pediatr Diabetes; 2014 Nov; 15(7):528-33. PubMed ID: 24552441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes.
    Björk E; Berne C; Kämpe O; Wibell L; Oskarsson P; Karlsson FA
    Diabetes; 1996 Oct; 45(10):1427-30. PubMed ID: 8826981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients.
    Osei K; Henry ML; O'Dorisio TM; Tesi RJ; Sommer BG; Ferguson RM
    Diabetes; 1990 Oct; 39(10):1235-42. PubMed ID: 2210076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children.
    Ludvigsson J; Heding L; Liedén G; Marner B; Lernmark A
    Br Med J (Clin Res Ed); 1983 Jan; 286(6360):176-8. PubMed ID: 6401518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
    Keymeulen B; Vandemeulebroucke E; Ziegler AG; Mathieu C; Kaufman L; Hale G; Gorus F; Goldman M; Walter M; Candon S; Schandene L; Crenier L; De Block C; Seigneurin JM; De Pauw P; Pierard D; Weets I; Rebello P; Bird P; Berrie E; Frewin M; Waldmann H; Bach JF; Pipeleers D; Chatenoud L
    N Engl J Med; 2005 Jun; 352(25):2598-608. PubMed ID: 15972866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a short prednisone regime at clinical onset of type 1 diabetes.
    Goday A; Pujol-Borrell R; Fernandez J; Casamitjana R; Rios M; Vilardell E; Gomis R
    Diabetes Res Clin Pract; 1993 Apr; 20(1):39-46. PubMed ID: 8344127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporin A in insulin-dependent diabetes mellitus of recent onset: a pilot study in children.
    Lévy-Marchal C; Czernichow P
    Horm Res; 1988; 29(5-6):177-84. PubMed ID: 3065205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.